Lithuanian Society of Gastroenterology

The Society was set up in Lithuania advisors Society of Gastroenterology Section in the year 1969. Self-Lithuanian Gastroenterology Society was framed in 1973. Unions were sorted out in 1973, 1978, 1983, 1988, 1993, 1997, 2001, 2005 and 2009. In 1995, lithuania gastroenterology society was admitted to the World Gastroenterology Organization. Lithuanian Republic of specialist doctors Societies position and proposals on the utilization of organic operators.

Therefore, the Republic of Lithuania master specialists relationship on the premise of the European Medicines Agency, the European Commission's rules to demonstrate their position and key suggestions identified with every single organic medication in solution and issue, considering their particular components and the way that comparable natural arrangements are equivalent to organic operators (reference), however not indistinguishable to them. To guarantee the sheltered utilization of comparable organic restorative items in the fitting make suggestions on these medications designation system.

• The Republic of Lithuania authority specialists Society concurs that comparative natural restorative items are pertinent to the human services framework and society, and recognizes the comparable organic therapeutic item quality, wellbeing and viability when they are enlisted as per European Union enactment.
• Biological specialists (counting the first item is biodegradable and it comparative arrangements) Consumption
• Do not naturally change the other one , since there are at present still no studies on the medication to each other (the reference restorative item and bio similar therapeutic item or an alternate reference drugs). A comparative natural restorative item, the dynamic substance is like an organic reference therapeutic dynamic substance; however it might be because of contrasts in their structure and many-sided quality of assembling procedures. Comparable organic restorative item, and in addition the reference therapeutic item, a specific level of normal variability. In this manner natural restorative items cannot be liable to the same tenets for compatibility, as non-specific pharmaceuticals.
• Decisions on the particular natural therapeutic item assignment for a specific patient or an organic restorative item trade with another (paying little respect to whether it is a unique organic restorative item or a comparable organic restorative item) should dependably embrace the treating doctor.
• Biological restorative items must not be exchangeable or comparable natural therapeutic items, because of financial reasons. Substitution treatment is just accessible if there is a clinical sign.
• Change one organic restorative items other conceivable purposes behind changing simply in the wake of talking about with the patient and with the educated assent.
• In request to guarantee the sheltered utilization of organic specialists and post-showcasing consistence with natural operators pharmacovigilance prerequisites, is required to guarantee traceability of therapeutic items, and natural medications must be recommended by demonstrating worldwide, as well as a patent (brand) name of the restorative item, and drug stores must be issued just alluded to the patent (brand) name natural items, as accommodated in the Lithuanian enactment (Minister of wellbeing in 2002. Walk eighth. arrange No. 112 "on pharmaceuticals receptųrašymo and administering of solutions (deals) substitution." the patient's restorative history and in addition the need to demonstrate the organic therapeutic item, the patient is dealt with universal, as well as a patent (brand) name of the therapeutic item.
• The choice for either biologics specialist is essential to have complete and target data on the most recent studies and information with the reference biologic medication, and with a comparative natural therapeutic item. It is imperative to know which tests have been enlisted as per the organic restorative item signs, ie, the signs enrolled by extrapolating the information accessible, and the sign depends on clinical trial information.

As per these rules in the Republic of Lithuania can accomplish a protected, effective, capable and cost-based treatment of patients.